Neogen (NEOG) Projected to Post Quarterly Earnings on Thursday

Neogen (NASDAQ:NEOG) is expected to issue its Q3 2026 results before the market opens on Thursday, April 9th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $204.6150 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2026 earning report page for the latest details on the call scheduled for Wednesday, April 8, 2026 at 8:00 AM ET.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings results on Thursday, January 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.03. Neogen had a positive return on equity of 2.14% and a negative net margin of 68.47%.The business had revenue of $224.69 million during the quarter, compared to the consensus estimate of $208.50 million. During the same quarter last year, the firm posted $0.11 EPS. The company’s quarterly revenue was down 2.9% on a year-over-year basis. On average, analysts expect Neogen to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Neogen Trading Up 1.6%

Shares of Neogen stock opened at $9.56 on Tuesday. The business has a fifty day simple moving average of $10.10 and a two-hundred day simple moving average of $7.93. Neogen has a 1 year low of $3.87 and a 1 year high of $11.43. The company has a market capitalization of $2.08 billion, a price-to-earnings ratio of -3.45 and a beta of 1.97. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.91 and a quick ratio of 2.80.

Analyst Upgrades and Downgrades

NEOG has been the subject of several research reports. Wall Street Zen raised Neogen from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Weiss Ratings reissued a “sell (e+)” rating on shares of Neogen in a report on Monday, December 29th. Piper Sandler reissued a “neutral” rating and set a $10.00 target price (up from $6.50) on shares of Neogen in a report on Monday, January 12th. CJS Securities raised Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 target price for the company in a report on Wednesday, December 10th. Finally, Guggenheim reissued a “buy” rating and set a $12.00 target price (up from $8.00) on shares of Neogen in a report on Friday, January 9th. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Neogen has a consensus rating of “Hold” and a consensus price target of $10.67.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of NEOG. Cibc World Markets Corp acquired a new position in Neogen in the fourth quarter valued at about $47,983,000. T. Rowe Price Investment Management Inc. raised its stake in Neogen by 249.2% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,181,768 shares of the company’s stock valued at $57,191,000 after purchasing an additional 5,838,570 shares in the last quarter. Bank of Montreal Can raised its stake in Neogen by 4,059.4% in the third quarter. Bank of Montreal Can now owns 4,592,218 shares of the company’s stock valued at $26,222,000 after purchasing an additional 4,481,812 shares in the last quarter. BNP Paribas Financial Markets raised its stake in Neogen by 809.8% in the third quarter. BNP Paribas Financial Markets now owns 2,660,884 shares of the company’s stock valued at $15,194,000 after purchasing an additional 2,368,410 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its stake in Neogen by 169.5% in the second quarter. Ameriprise Financial Inc. now owns 3,079,123 shares of the company’s stock valued at $14,718,000 after purchasing an additional 1,936,569 shares in the last quarter. Institutional investors and hedge funds own 96.73% of the company’s stock.

Neogen Company Profile

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.